Replies to post #13648 on Marker Therapeutics Inc (MRKR)

[Rkmatters]

That's not actually true. GALE's market cap is $165 million. TPIV's is $38 million. In order for TPIV to have the same market cap as its peer, it would trade around $2.50. For GALE to have the equivalent value to TPIV, it would trade around $.23. Both have room for growth though. If GALE is successful, TPIV will become more valuable. If GALE fails, well TPIV has already shown to be the superior technology.